Fulvio Foschini,Marcello Stagni,Giulio Luciani,Pierre Roy
申请号：
US14353872
公开号：
US09439908B2
申请日:
2012.10.24
申请国别(地区):
US
年份:
2016
代理人:
摘要：
An improved formulation of an ophthalmic composition contains riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the treatment of keratoconus.
